NewLink Genetics to Participate in the Baird Global Healthcare Conference

AMES, Iowa, Aug. 21, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK) announced today that the company will present at the 2018 Baird Global Healthcare Conference on Wednesday, September 5, 2018, at 11:25AM ET. 

A live webcast of the presentation will be available on the Company’s website at www.newlinkgenetics.com in the “Investors & Media” section under “Events and Presentations.”  An archived edition of the presentation will be available on the Company’s website later that day. 

About NewLink Genetics Corporation

NewLink Genetics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' leading drug candidate, indoximod, is an investigational, orally available small molecule designed to harness multiple components of the immune system to combat cancer. For more information, please visit www.newlinkgenetics.com and follow us on Twitter @NLNKGenetics.

Investor Contact:

Lisa MillerDirector of Investor RelationsNewLink Genetics515-598-2555[email protected]

Media Contact:

Sharon CorreiaVP, Integrated CommunicationsLaVoieHealthScience617-374-8800, ext. 105[email protected]

Source: NewLink Genetics Corporation

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Upstage AI Unveils Solar Pro 4, Scoring 42 on Artificial Analysis Index to Rank Among Global Frontier Models
• Agiloft Announces Agiloft for Salesforce on Salesforce AgentExchange
• Marco's Pizza Ranks as a Top Franchise Brand on 2026 QSR 50 List